Cancer Genomics

Exact Sciences Stock Expands into Liquid Biopsy Market

Did you know that as early as the 1930s scientists were using wastewater – specifically, human excreta – to track disease outbreaks like polio well before the Rona came to town? Here’s another interesting scientific scoop on poop: One of the best treatments for people suffering from a serious bacterial gut infection is a fecal […]

Why We No Longer Like Personalis Stock

As our tech investing methodology evolves, new rules help us better avoid risks and pitfalls by choosing companies that have proven their potential. Meaningful revenue of $10 million per year or more demonstrates traction, provided it’s not in the form of government grants. The larger the company, the more likely they’ll be able to raise […]

SOPHiA GENETICS Stock – A Play on Data Driven Medicine

When artificial intelligence (AI) algorithms are able to predict how proteins fold based on amino acid sequences, it makes one wonder why it’s taking so long to move from spray-and-pray medicine to data-driven medicine. Today’s AI algorithms are certainly sophisticated enough, and there’s plenty of delicious big data to be found. The problem lies in […]

A Pure-Play Stock for Investing in Cancer Genomics

Saint Steve Jobs once said that the biggest innovations of the twenty-first century will be at the intersection of biology and technology. Look no further than next-generation sequencing (NGS) which now lets us read DNA, and artificial intelligence algorithms that help us understand DNA. If we think of a DNA strand as a 1.5-gigabyte chunk of computer […]

ArcherDX Promises Precision Oncology For All

Trying to monitor what’s happening in the disruptive technology space is a difficult task, especially in the broad area of life sciences. We try to keep tabs on any IPO which dabbles in any of the 60 disruptive technology themes we research here at Nanalyze. Usually, we’ll have come across a company prior to their […]

9 Genomics Startups for Investors to Watch

The history of direct-to-consumer genomics tests goes something like this. Genomics startups first started offering hereditary tests that required a DNA sample and everyone quickly climbed on board without realizing just how much information they were handing over to people they didn’t really know that well. Eventually, testing companies started moving into DNA health tests and then the FDA […]

Exact Sciences’ Stock is Soaring – Here’s Why

In a recent article, we talked about how the mythical “cure for cancer” doesn’t actually exist. There is no one-size-fits-all cure for the over 100 types of cancer out there, not to mention the advances being made in cancer genomics that show just how many unique variations of cancer there are. Everyone’s cancer is unique, and the […]

The Biggest Liquid Biopsy Company Files for IPO

We’re not sure about other countries out there, but here in ‘Murica “curing cancer” is kind of a big deal. Everyone seems to think that there’s some magical potion that cures cancer. Some people think the “cure for cancer” is being hidden by “big pharma” so they can make billions of dollars on cancer treatments. […]

An Introduction to Cancer Immunotherapy Treatments

Of all the things that your doctor could tell you that might be a cause for alarm, hearing that you have late-stage cancer is probably one of the worst. We’ve all heard people talk about a “cure for cancer” when in fact there is no one single cure. However, things are starting to look up […]

Personalized Cancer Care with FoundationOne CDx

The term “cure for cancer” is misleading as it implies there is one single problem that needs to be solved in order to eradicate all cancers. This couldn’t be further from the truth. There are 5 main cancer groups which are further subdivided into more than 200 different types of cancer. There won’t be a single […]